Prescription Voriconazole Antifungal Tablets Recalled Nationwide for Manufacturing Deviations
Glenmark Pharmaceuticals is voluntarily recalling Voriconazole tablets nationwide due to manufacturing process deviations. No illnesses or injuries have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a voluntary Class II recall due to manufacturing process deviations with no reported illnesses, injuries, or deaths. The recall addresses quality control compliance issues rather than a confirmed product hazard.
Plain-English summary
Glenmark Pharmaceuticals Inc. USA is voluntarily recalling Voriconazole tablets (200 mg, 30-count bottles) due to manufacturing process deviations identified as Current Good Manufacturing Practice (CGMP) violations. The FDA classified this as a Class II recall. Voriconazole is an antifungal medication.
Eight lots of the product with expiration dates ranging from March 2025 to September 2026 are affected by the recall. Distribution has been nationwide throughout the United States. No illnesses or injuries related to this product have been reported.
Consumers who have Voriconazole from one of the affected lots should contact their pharmacist or healthcare provider for further information and guidance regarding their use of the product.
The recalled product
- Product
- VORICONAZOLE (VORICONAZOLE)
- Brand
- VORICONAZOLE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug — Antifungal
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot # 17230853
- exp. date Mar-25 17231271
- exp. date May-25 17231300
- exp. date May-25 17242050
- exp. date Oct-26 17231046
- exp. date Apr-25 17241156
- exp. date Jun-26 17241388
- exp. date Jul-26 17241800
- exp. date Sep-26
UPCs (1)
- 0368462573303
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · VORICONAZOLE
- ModerateGlenmark Voriconazole Tablets Recalled for Manufacturing Process Deviations
FDA (Drugs) · 2025-04-16
- ModerateVoriconazole Tablets Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2025-04-09
- HighVoriconazole Oral Suspension Recalled for Missing Package Insert
FDA (Drugs) · 2024-02-28
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27